LncRNA EIF3J‐DT promotes chemoresistance in oral squamous cell carcinoma
Oral Diseases · 2024
DOI: 10.1111/odi.14987 ↗At a glance
Journal article in Oral Diseases, 2024. Written by Seon Hyun Kim and 4 co-authors. Institution: Periodontal Disease Signaling Network Research Center (MRC), School of Dentistry, Pusan National University, Yangsan, Korea. Major MEDLINE topics: Mouth Neoplasms, Drug Resistance, Neoplasm, Paclitaxel, Carcinoma, Squamous Cell. Cited 3 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Research Foundation of Korea (NRF) Grant funded by the Korea government (MSIT), Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT, National Research Foundation of Korea.
Abstract (original language)
Objectives
This study aimed to screen oral squamous cell carcinoma (OSCC) diagnostic and prognostic candidates and investigate the potential functions and mechanisms of candidates in the chemoresistance of OSCC cell lines. Materials and Methods Differential expression profiling of lncRNA was performed in a large cohort of OSCC patients from the Cancer Genome Atlas database to identify OSCC diagnostic and prognostic candidates. Taxol resistance in OSCC cell lines was analyzed using MTT assay. OSCC cell lines transfected with EIF3J‐DT pcDNA or siRNA were used to determine its regulatory effects on apoptosis, cell cycle distribution and autophagy using flow cytometry and western blot.
Results
We identified EIF3J‐DT as a candidate for OSCC diagnosis and prognosis. The expression level of EIF3J‐DT in OSCC cell lines correlates with taxol resistance. EIF3J‐DT silencing attenuated taxol resistance, and EIF3J‐DT overexpression enhanced taxol resistance in OSCC cell lines. Silencing of EIF3J‐DT reduced taxol resistance by inducing apoptosis, cell cycle arrest, and ATG14‐mediated autophagy inhibition in OSCC cell lines.
Conclusions
We found that EIF3J‐DT induced chemoresistance by regulating apoptosis, cell cycle, and autophagy in OSCC cell lines, which EIF3J‐DT might provide a novel therapeutic approach for OSCC as well as a diagnostic and prognostic factor.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Periodontal Disease Signaling Network Research Center (MRC), School of Dentistry, Pusan National University, Yangsan, Korea.
- Interdisciplinary Program of Genomic Data Science, Pusan National University, Yangsan, Korea.
- Department of Anatomy, School of Medicine, Pusan National University, Yangsan, Korea.
- Department of Biomedical Informatics, School of Medicine, Pusan National University, Yangsan, Korea.
- Department of Oral Pathology, Dental & Life Science Institute, School of Dentistry, Pusan National University, Yangsan, Korea.
ORCID profiles: Hye Jung Kim, Yun Hak Kim, Hae Ryoun Park
Funding
- National Research Foundation of Korea (NRF) Grant funded by the Korea government (MSIT)
- Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT
- National Research Foundation of Korea
Cite
APA
Kim, S. H., Kim, H. J., Kim, Y. J., Kim, Y. H., & Park, H. R. (2024). LncRNA EIF3J‐DT promotes chemoresistance in oral squamous cell carcinoma. Oral Diseases. https://doi.org/10.1111/odi.14987
Vancouver
Kim SH, Kim HJ, Kim YJ, Kim YH, Park HR. LncRNA EIF3J‐DT promotes chemoresistance in oral squamous cell carcinoma. Oral Diseases. 2024. doi:10.1111/odi.14987
BibTeX
@article{Kim2024,
author = {Kim, Seon Hyun and Kim, Hye Jung and Kim, Yeong Joo and Kim, Yun Hak and Park, Hae Ryoun},
title = {LncRNA EIF3J‐DT promotes chemoresistance in oral squamous cell carcinoma},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14987}
}
EUVIMED